1. Academic Validation
  2. 15-Lipoxygenase-1 biosynthesis of 7S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5

15-Lipoxygenase-1 biosynthesis of 7S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5

  • J Lipid Res. 2020 Jul;61(7):1087-1103. doi: 10.1194/jlr.RA120000777.
Steven C Perry 1 Chakrapani Kalyanaraman 2 Benjamin E Tourdot 3 William S Conrad 1 Oluwayomi Akinkugbe 1 John Cody Freedman 1 Michael Holinstat 3 Matthew P Jacobson 2 Theodore R Holman 4
Affiliations

Affiliations

  • 1 Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064.
  • 2 Department of Pharmaceutical Chemistry, School of Pharmacy, University of California San Francisco, San Francisco, CA 94143.
  • 3 Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI 48109.
  • 4 Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064. Electronic address: mailto:holman@ucsc.edu.
Abstract

The two oxylipins 7S,14S-dihydroxydocosahexaenoic acid (diHDHA) and 7S,17S-diHDHA [resolvin D5 (RvD5)] have been found in macrophages and infectious inflammatory exudates and are believed to function as specialized pro-resolving mediators (SPMs). Their biosynthesis is thought to proceed through sequential oxidations of DHA by Lipoxygenase (LOX) Enzymes, specifically, by human 5-LOX (h5-LOX) first to 7(S)-hydroxy-4Z,8E,10Z,13Z,16Z,19Z-DHA (7S-HDHA), followed by human platelet 12-LOX (h12-LOX) to form 7(S),14(S)-dihydroxy-4Z,8E,10Z,12E,16Z,19Z-DHA (7S,14S-diHDHA) or human reticulocyte 15-LOX-1 (h15-LOX-1) to form RvD5. In this work, we determined that oxidation of 7(S)-hydroperoxy-4Z,8E,10Z,13Z,16Z,19Z-DHA to 7S,14S-diHDHA is performed with similar kinetics by either h12-LOX or h15-LOX-1. The oxidation at C14 of DHA by h12-LOX was expected, but the noncanonical reaction of h15-LOX-1 to make over 80% 7S,14S-diHDHA was larger than expected. Results of computer modeling suggested that the alcohol on C7 of 7S-HDHA hydrogen bonds with the backbone carbonyl of Ile399, forcing the hydrogen abstraction from C12 to oxygenate on C14 but not C17. This result raised questions regarding the synthesis of RvD5. Strikingly, we found that h15-LOX-2 oxygenates 7S-HDHA almost exclusively at C17, forming RvD5 with faster kinetics than does h15-LOX-1. The presence of h15-LOX-2 in neutrophils and macrophages suggests that it may have a greater role in biosynthesizing SPMs than previously thought. We also determined that the reactions of h5-LOX with 14(S)-hydroperoxy-4Z,7Z,10Z,12E,16Z,19Z-DHA and 17(S)-hydroperoxy-4Z,7Z,10Z,13Z,15E,19Z-DHA are kinetically slow compared with DHA, suggesting that these reactions may be minor biosynthetic routes in vivo. Additionally, we show that 7S,14S-diHDHA and RvD5 have anti-aggregation properties with platelets at low micromolar potencies, which could directly regulate clot resolution.

Keywords

7(S),14(S)-dihydroxy-4Z,8E,10Z,12E,16Z,19Z-docosahexaenoic acid; 7-hydroxydocosahexaenoic acid; docosahexaenoic acid; enzymology; human reticulocyte 15-lipoxygenase-1; kinetics; maresin; mass spectrometry; molecular modeling; omega-3 fatty acid; platelets.

Figures